NasdaqGS - Nasdaq Real Time Price • USD
CG Oncology, Inc. (CGON)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 5:38 PM EDT
Major Holders
| Breakdown | |
|---|---|
| 7.05% | % of Shares Held by All Insider |
| 72.14% | % of Shares Held by Institutions |
| 77.61% | % of Float Held by Institutions |
| 128 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Decheng Capital LLC | 5.46M | Mar 31, 2024 | 8.19% | 177,029,209 |
| TCG Crossover Management, LLC | 3.57M | Mar 31, 2024 | 5.36% | 115,781,781 |
| Blackrock Inc. | 2.52M | Mar 31, 2024 | 3.78% | 81,676,577 |
| Vanguard Group Inc | 2.23M | Mar 31, 2024 | 3.34% | 72,157,334 |
| BVF Inc. | 1.88M | Mar 31, 2024 | 2.83% | 61,104,314 |
| Janus Henderson Group PLC | 1.52M | Mar 31, 2024 | 2.28% | 49,340,040 |
| Avidity Partners Management, LP | 1.45M | Mar 31, 2024 | 2.18% | 47,178,029 |
| RA Capital Management, L.P. | 1.4M | Mar 31, 2024 | 2.10% | 45,318,752 |
| Perceptive Advisors Llc | 1.3M | Mar 31, 2024 | 1.96% | 42,292,125 |
| Braidwell LP | 1.13M | Mar 31, 2024 | 1.70% | 36,653,521 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 568.67k | Mar 31, 2024 | 0.85% | 18,442,130 |
| AB Cap Fd.-AB Small Cap Growth Port | 517.44k | Mar 31, 2024 | 0.78% | 16,780,579 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 297.01k | Feb 29, 2024 | 0.45% | 9,631,937 |
| Franklin Strategic Series-Franklin Small-Mid Cap Growth | 287.6k | Jan 31, 2024 | 0.43% | 9,326,868 |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 197.8k | Jan 31, 2024 | 0.30% | 6,414,654 |
| MFS New Discovery Fund | 171.1k | Feb 29, 2024 | 0.26% | 5,548,805 |
| Principal Small Cap Growth Fd I | 120.05k | Jan 31, 2024 | 0.18% | 3,893,318 |
| iShares Russell 2000 Value ETF | 121.29k | Mar 31, 2024 | 0.18% | 3,933,434 |
| Fidelity Extended Market Index Fund | 116.3k | Mar 31, 2024 | 0.17% | 3,771,479 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 101.6k | Jan 31, 2024 | 0.15% | 3,294,888 |
Related Tickers
KYTX Kyverna Therapeutics, Inc.
13.23
+1.77%
APGE Apogee Therapeutics, Inc.
47.86
-0.35%
AVBP ArriVent BioPharma, Inc.
18.97
-1.40%
LEGN Legend Biotech Corporation
41.68
+0.65%
MRUS Merus N.V.
54.87
-8.53%
ANRO Alto Neuroscience, Inc.
12.28
-4.95%
IMCR Immunocore Holdings plc
46.30
+0.54%
CRNX Crinetics Pharmaceuticals, Inc.
46.86
-1.29%
EWTX Edgewise Therapeutics, Inc.
17.16
+0.29%
CGEM Cullinan Therapeutics, Inc.
23.03
-4.56%